Evidence map›Paper›PMID 32647256›Full record

ArticleScientific reports2020

Antimicrobial activity of Epsilon-Poly-L-lysine against phytopathogenic bacteria.

Bárbara Rodrigues, Tâmara P Morais, Paulo A Zaini, Cássio S Campos, Hebréia O Almeida-Souza, Abhaya M Dandekar, Rafael Nascimento, Luiz R Goulart

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Microorganisms · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. A Study of Type II ɛ-PL Degrading Enzyme (pldII) inInternational journal of molecular sciences · 2022
    Article
  19. Article
  20. AntimicrobialAntibiotics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bárbara RodriguesLaboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil.
Tâmara P MoraisLaboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil.
Paulo A ZainiDepartment of Plant Sciences, University of California, Davis, Davis, CA, USA.
Cássio S CamposLaboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil.
Hebréia O Almeida-SouzaLaboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil.
Abhaya M DandekarDepartment of Plant Sciences, University of California, Davis, Davis, CA, USA.
Rafael NascimentoLaboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil.
Luiz R GoulartLaboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil. lrgoulart@ufu.br.
Universidade Federal de Uberlândia · BRUniversity of California, Davis · USInstituto Federal de Educação, Ciência e Tecnologia de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are components of immune defense in many organisms, including plants. They combat pathogens due to their antiviral, antifungal and antibacterial properties, and are considered potential therapeutic agents. An example of AMP is Epsilon-Poly-L-lysine (EPL), a polypeptide formed by ~ 25 lysine residues with known antimicrobial activity against several human microbial pathogens. EPL presents some advantages such as good water solubility, thermal stability, biodegradability, and low toxicity, being a candidate for the control of phytopathogens. Our aim was to evaluate the antimicrobial activity of EPL against four phytobacterial species spanning different classes within the Gram-negative phylum Proteobacteria: Agrobacterium tumefaciens (syn. Rhizobium radiobacter), Ralstonia solanacearum, Xanthomonas citri subsp. citri (X. citri), and Xanthomonas euvesicatoria. The minimum inhibitory concentration (MIC) of the peptide ranged from 80 μg/ml for X. citri to 600 μg/ml for R. solanacearum and X. euvesicatoria. Two hours of MIC exposure led to pathogen death due to cell lysis and was enough for pathogen clearance. The protective and curative effects of EPL were demonstrated on tomato plants inoculated with X. euvesicatoria. Plants showed less disease severity when sprayed with EPL solution, making it a promising natural product for the control of plant diseases caused by diverse Proteobacteria.

Indexed as

Anti-Bacterial AgentsGram-Negative BacteriaPlant DiseasesPolylysineSolanum lycopersicumAnti-Bacterial AgentsPolylysine

Identifiers

PMID32647256
PMCPMC7347836
OpenAlexW3041256382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.